Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT02573701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico

Active Ingredients

Drugs in Phase 4 Trials (2)

celecoxib (celebrex) (1 trial)

minocycline (minocin) (1 trial)

Drugs in Phase 3 Trials (1)

fluoxetine (prozac) (1 trial)

Drugs in Other Trials (1)

risperidone (risperdal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4